Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 03 symbols : Ebs save search
New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses
Published: 2021-05-03 (Crawled : 21:00) - globenewswire.com
EBS | News | $2.18 -4.8% 3.21% 750K
|
Health Technology
|
| O: -1.2%
H: 0.62%
C: -2.88%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M
|
Health Technology
|
| O: 18.45%
H: 0.53%
C: -7.79%
covid vaccine
Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
EBS | News | $2.18 -4.8% 3.21% 750K
|
Health Technology
|
| O: 0.61%
H: 0.96%
C: 0.39%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M
|
Health Technology
|
| O: -7.51%
H: 5.92%
C: -19.56%
financial results results
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.